# EDGAR Filing Document

**Accession Number:** 0001954488
**File Stem:** 0001213900-25-053881
**Filing Date:** 2025-6
**Character Count:** 2529
**Document Hash:** 294aa68632055d73a8a5dbd721716770
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-053881.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001213900-25-053881

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Jyong Biotech Ltd.
- **CENTRAL INDEX KEY:** 0001954488
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 23F-3, NO.95, SEC. 1, XINTAI 5TH RD.
- **STREET 2:** XIZHI DIST.
- **CITY:** NEW TAIPEI CITY
- **STATE:** F5
- **ZIP:** 221
- **BUSINESS PHONE:** (8862) 27325205

**MAIL ADDRESS:**
- **STREET 1:** 23F-3, NO.95, SEC. 1, XINTAI 5TH RD.
- **STREET 2:** XIZHI DIST.
- **CITY:** NEW TAIPEI CITY
- **STATE:** F5
- **ZIP:** 221

**Joseph Stone Capital, LLC**

**<u>Via EDGAR</u>**

June 12, 2025

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C., 20549

Attention: Doris Stacey <br> Suzanne Hayes Ibolya Ignat Mary Mast

---

| | |
|:---|:---|
| **Re:** | **Jyong Biotech Ltd.** |
|  | **Registration Statement on Form F-1, as amended** |
|  | **Initially Filed on March 7, 2024** |
|  | **File No. 333-277725** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Joseph Stone Capital, LLC, as the representative of underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m., Eastern Time, on June 16, 2025, or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, we wish to advise you that we will take reasonable steps to secure adequate distribution of the preliminary prospectus to underwriters, dealers, institutions and others prior to the requested effective time of the Registration Statement.

We have been advised by the prospective underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,

---

| | |
|:---|:---|
| **Joseph Stone Capital, LLC** | **Joseph Stone Capital, LLC** |
| By: | /s/Damian Maggio |
| Name: | Damian Maggio |
| Title: | Chief Executive Officer |

---